| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/17/2004 | CN1547587A Process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof |
| 11/17/2004 | CN1547486A Antibodies to OPGL |
| 11/17/2004 | CN1547485A 疫苗组合物 Vaccine compositions |
| 11/17/2004 | CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy |
| 11/17/2004 | CN1547480A Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivati |
| 11/17/2004 | CN1547023A Immune colloidal gold reagent for detecting cefalexin and preparation method thereof |
| 11/17/2004 | CN1547022A Immune colloidal gold reagent for detecting Aiibi-bacterin and preparation method thereof |
| 11/17/2004 | CN1547021A Immune colloidal gold reagent for detecting chloromycetin and preparation method thereof |
| 11/17/2004 | CN1547020A Immune colloidal gold reagent for detecting streptomycin and preparation method thereof |
| 11/17/2004 | CN1547019A Immune colloidal gold reagent for detecting stilboestrol and preparation method thereof |
| 11/17/2004 | CN1547018A Immune colloidal gold reagent for detecting dihydrodiethylstilbestrol and preparation method thereof |
| 11/17/2004 | CN1547017A Immune colloidal gold reagent for detecting sulfamethyldiazine and preparation method thereof |
| 11/17/2004 | CN1547016A Immune colloidal gold reagent for detecting sulfamethazine and preparation method thereof |
| 11/17/2004 | CN1547015A Immune colloidal gold reagent for detecting ciprofloxacin and preparation method thereof |
| 11/17/2004 | CN1547014A Immune colloidal gold reagent for detecting zearanol and preparation method thereof |
| 11/17/2004 | CN1546664A Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses |
| 11/17/2004 | CN1546662A Recombinant caspase-6 gene having target activity and its uses in treating tumor |
| 11/17/2004 | CN1546658A Artificially recombinant H9N2 hypotype influenza virus and its uses |
| 11/17/2004 | CN1546657A Virus lysis method |
| 11/17/2004 | CN1546527A Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application |
| 11/17/2004 | CN1546522A Alkaline fibroblast growth factor antigen epitope peptide and its screening method |
| 11/17/2004 | CN1546521A Transfer factor specific for SARS virus and method for preparing same |
| 11/17/2004 | CN1546515A Immune RNA specific for SARS virus and method for preparing same |
| 11/17/2004 | CN1546514A Nucleotide specific for escherichia coli 0141 O-antigen |
| 11/17/2004 | CN1546513A Nucleotide specific for escherichia coli 0151 O-antigen |
| 11/17/2004 | CN1546512A Nucleotide specific for escherichia coli 0156 O-antigen |
| 11/17/2004 | CN1546511A Nucleotide specific for escherichia coli 0159 O-antigen |
| 11/17/2004 | CN1546510A Nucleotide specific for shigella bodyii 10 O-antigen |
| 11/17/2004 | CN1546509A Nucleotide specific for escherichia coli 054 O-antigen |
| 11/17/2004 | CN1546508A Nucleotide specific for shigella bodyii 2 O-antigen |
| 11/17/2004 | CN1546172A Hyper-immune serum for resisting SARS virus and its preparation |
| 11/17/2004 | CN1176210C Novel type coronavirus |
| 11/17/2004 | CN1175903C Preparation of deactivated dual vibrio vaccine for sea fish |
| 11/16/2004 | WO2006009525A2 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 11/16/2004 | US6818751 Antigen presenting cell expressing prostate-specific protein; for prevention/monitoring |
| 11/16/2004 | US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders |
| 11/16/2004 | US6818748 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against Venezuelan equine encephalitis virus (VEE) |
| 11/16/2004 | US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin) |
| 11/16/2004 | US6818743 Intercellular adhesion molecule (i-cam) for modulation of ligand/receptor binding/cloning reactions; drug screening of antiinflammatory/anticancer agents; genetic engineering |
| 11/16/2004 | US6818628 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus |
| 11/16/2004 | US6818448 Isolated cell comprising HAPP 670/671 DNAS sequences |
| 11/16/2004 | US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 11/16/2004 | US6818223 Abundant extracellular products and methods for their production and use |
| 11/16/2004 | US6818222 Particularly from pertussis, cholera and heat labile e. coli |
| 11/16/2004 | US6818221 Adjuvants and processes to induce a specific type of immune response |
| 11/16/2004 | US6818218 Prevention and treatment of amyloidogenic disease |
| 11/16/2004 | US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity |
| 11/16/2004 | US6818213 Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
| 11/16/2004 | CA2525291A1 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 11/16/2004 | CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 11/16/2004 | CA2120342C Epstein-barr virus peptides and antibodies against these peptides |
| 11/16/2004 | CA2059692C Pneumoccoccal polysaccharide conjugate vaccine |
| 11/11/2004 | WO2004097000A2 Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions |
| 11/11/2004 | WO2004096993A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 11/11/2004 | WO2004096989A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 11/11/2004 | WO2004096976A2 Spex compositions and methods of use |
| 11/11/2004 | WO2004096844A2 Group 1 mite polypeptide variants |
| 11/11/2004 | WO2004096273A1 Methods for treating interleukin-6 related diseases |
| 11/11/2004 | WO2004096270A1 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates |
| 11/11/2004 | WO2004096244A1 Method of preparing tumor vaccine for the inducement of anti-tumor activity and a pharmaceutical composition containing the same |
| 11/11/2004 | WO2004096157A2 Treatment of igai deposition diseases |
| 11/11/2004 | WO2004096144A2 Compositions and methods for induction of opioid receptors |
| 11/11/2004 | WO2004096136A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 11/11/2004 | WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor |
| 11/11/2004 | WO2004083374A3 Methods for screening for an antigen for use in a vaccine |
| 11/11/2004 | WO2004081515A3 Purification process for bacterial cytolysin |
| 11/11/2004 | WO2004069863A3 Constrained hiv v3 loop peptides as immunogens and receptor antagonists |
| 11/11/2004 | WO2004069274A3 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 11/11/2004 | WO2004065558A8 Depletion of endogenous primordial germ cells in avian species |
| 11/11/2004 | WO2004058801A3 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 11/11/2004 | WO2004054508A3 Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments |
| 11/11/2004 | WO2004039400A3 Bhv5 mutants |
| 11/11/2004 | WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 11/11/2004 | WO2004020404A3 Modified transferin-antibody fusion proteins |
| 11/11/2004 | WO2004015070A3 Isolation and identification of t cells |
| 11/11/2004 | WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen |
| 11/11/2004 | WO2004010935A3 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 11/11/2004 | WO2003102166A8 Novel flavivirus antigens |
| 11/11/2004 | WO2003084988A3 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes |
| 11/11/2004 | WO2003051285A3 Therapeutic anti-hiv (iv9) compounds |
| 11/11/2004 | WO2003038052A3 Nucleic acid-associated proteins |
| 11/11/2004 | WO2002096350A3 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 11/11/2004 | WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 11/11/2004 | WO2002031117A3 Clasp-2 transmembrane proteins |
| 11/11/2004 | US20040225118 31 human secreted proteins |
| 11/11/2004 | US20040224919 Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 11/11/2004 | US20040224893 administering interleukin-1 antagonists; restenosis, atherosclerosis, vascular access dysfunction; anticholesterol, hypotensive agents |
| 11/11/2004 | US20040224891 Methods for the early diagnosis of ovarian cancer |
| 11/11/2004 | US20040224885 Methods of treating hypertension and compositions for use therein |
| 11/11/2004 | US20040224386 Protein tyrosine kinases |
| 11/11/2004 | US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs |
| 11/11/2004 | US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents |
| 11/11/2004 | US20040224360 Methods for diagnosing renal disorders |
| 11/11/2004 | US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy |
| 11/11/2004 | US20040224350 Dirofilaria non-collagenous protein for use in developing vaccine for prevention and treatment of nematode infection; veterinary medicine |
| 11/11/2004 | US20040224347 Methods for identification, diagnosis, and treatment of breast cancer |
| 11/11/2004 | US20040224327 Modified open reading frames comprised of ribonucleic acid sequences from non infectious porcine reproductive respiratory syndrome virus for use in generation of vaccine to prevent viral infection of pigs; veterinay medicine |
| 11/11/2004 | US20040224310 Anti-paratopic antibody as an immunogen |
| 11/11/2004 | US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
| 11/11/2004 | US20040224305 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |